Voyager Therapeutics (VYGR) Free Cash Flow (QoQ) (2015 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) Free Cash Flow (QoQ) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Voyager Therapeutics | 195.27 Mn | 78.93 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.11% |
| Mar 31, 2026 | -8.24% |
| Dec 31, 2025 | 1.17% |
| Sep 30, 2025 | 9.05% |
| Jun 30, 2025 | 10.86% |
| Mar 31, 2025 | -162.55% |
| Dec 31, 2024 | 47.98% |
| Sep 30, 2024 | 13.28% |
| Jun 30, 2024 | -157.48% |
| Mar 31, 2024 | 330.99% |
| Dec 31, 2023 | -12.28% |
| Sep 30, 2023 | -967.63% |
| Jun 30, 2023 | -101.66% |
| Mar 31, 2023 | 1,033.87% |
| Dec 31, 2022 | 20.06% |
| Sep 30, 2022 | 15.63% |
| Jun 30, 2022 | -157.13% |
| Mar 31, 2022 | 215.25% |
| Dec 31, 2021 | 150.77% |
| Sep 30, 2021 | 6.86% |